These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25537281)

  • 1. Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes.
    Ohi K; Hashimoto R; Ikeda M; Yamamori H; Yasuda Y; Fujimoto M; Umeda-Yano S; Fukunaga M; Fujino H; Watanabe Y; Iwase M; Kazui H; Iwata N; Weinberger DR; Takeda M
    Schizophr Bull; 2015 Jul; 41(4):909-18. PubMed ID: 25537281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.
    Walters JT; Rujescu D; Franke B; Giegling I; Vásquez AA; Hargreaves A; Russo G; Morris DW; Hoogman M; Da Costa A; Moskvina V; Fernández G; Gill M; Corvin A; O'Donovan MC; Donohoe G; Owen MJ
    Am J Psychiatry; 2013 Aug; 170(8):877-85. PubMed ID: 23903335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function.
    LeBlanc M; Kulle B; Sundet K; Agartz I; Melle I; Djurovic S; Frigessi A; Andreassen OA
    J Psychiatr Res; 2012 Feb; 46(2):271-8. PubMed ID: 22126837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk.
    Kos MZ; Carless MA; Peralta J; Blackburn A; Almeida M; Roalf D; Pogue-Geile MF; Prasad K; Gur RC; Nimgaonkar V; Curran JE; Duggirala R; Glahn DC; Blangero J; Gur RE; Almasy L
    Schizophr Bull; 2016 Mar; 42(2):288-300. PubMed ID: 26405221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results and promises of genetics of cognitive impairment in schizophrenia: molecular-genetic approaches].
    Alfimova MV; Kondratiev NV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):137-144. PubMed ID: 28635752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
    McClay JL; Adkins DE; Aberg K; Bukszár J; Khachane AN; Keefe RS; Perkins DO; McEvoy JP; Stroup TS; Vann RE; Beardsley PM; Lieberman JA; Sullivan PF; van den Oord EJ
    Neuropsychopharmacology; 2011 Feb; 36(3):616-26. PubMed ID: 21107309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia.
    Bakken TE; Bloss CS; Roddey JC; Joyner AH; Rimol LM; Djurovic S; Melle I; Sundet K; Agartz I; Andreassen OA; Dale AM; Schork NJ
    Arch Gen Psychiatry; 2011 Aug; 68(8):781-90. PubMed ID: 21810643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter.
    Treutlein J; Mühleisen TW; Frank J; Mattheisen M; Herms S; Ludwig KU; Treutlein T; Schmael C; Strohmaier J; Bösshenz KV; Breuer R; Paul T; Witt SH; Schulze TG; Schlösser RG; Nenadic I; Sauer H; Becker T; Maier W; Cichon S; Nöthen MM; Rietschel M
    Schizophr Res; 2009 Jun; 111(1-3):123-30. PubMed ID: 19346103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEGS2 polymorphism associated with cognition in schizophrenia is associated with gene expression in brain.
    Ohi K; Ursini G; Li M; Shin JH; Ye T; Chen Q; Tao R; Kleinman JE; Hyde TM; Hashimoto R; Weinberger DR
    Transl Psychiatry; 2015 Apr; 5(4):e550. PubMed ID: 25871975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.
    Shibata H; Tani A; Chikuhara T; Kikuta R; Sakai M; Ninomiya H; Tashiro N; Iwata N; Ozaki N; Fukumaki Y
    Psychiatry Res; 2009 May; 167(1-2):88-96. PubMed ID: 19351574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of cognitive impairment in schizophrenia: a phenomic perspective.
    Bilder RM; Howe A; Novak N; Sabb FW; Parker DS
    Trends Cogn Sci; 2011 Sep; 15(9):428-35. PubMed ID: 21816658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Genetic Loci Jointly Influencing Schizophrenia Risk and the Cognitive Traits of Verbal-Numerical Reasoning, Reaction Time, and General Cognitive Function.
    Smeland OB; Frei O; Kauppi K; Hill WD; Li W; Wang Y; Krull F; Bettella F; Eriksen JA; Witoelar A; Davies G; Fan CC; Thompson WK; Lam M; Lencz T; Chen CH; Ueland T; Jönsson EG; Djurovic S; Deary IJ; Dale AM; Andreassen OA;
    JAMA Psychiatry; 2017 Oct; 74(10):1065-1075. PubMed ID: 28746715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive analysis of schizophrenia risk genes that function as epigenetic regulators of gene expression.
    Whitton L; Cosgrove D; Clarkson C; Harold D; Kendall K; Richards A; Mantripragada K; Owen MJ; O'Donovan MC; Walters J; Hartmann A; Konte B; Rujescu D; ; Gill M; Corvin A; Rea S; Donohoe G; Morris DW
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1170-1179. PubMed ID: 27762073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.
    Suárez-Rama JJ; Arrojo M; Sobrino B; Amigo J; Brenlla J; Agra S; Paz E; Brión M; Carracedo Á; Páramo M; Costas J
    J Psychiatr Res; 2015; 66-67():38-44. PubMed ID: 25943950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic association study of CSMD1 and CSMD2 with cognitive function.
    Athanasiu L; Giddaluru S; Fernandes C; Christoforou A; Reinvang I; Lundervold AJ; Nilsson LG; Kauppi K; Adolfsson R; Eriksson E; Sundet K; Djurovic S; Espeseth T; Nyberg L; Steen VM; Andreassen OA; Le Hellard S
    Brain Behav Immun; 2017 Mar; 61():209-216. PubMed ID: 27890662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients.
    Koide T; Banno M; Aleksic B; Yamashita S; Kikuchi T; Kohmura K; Adachi Y; Kawano N; Kushima I; Nakamura Y; Okada T; Ikeda M; Ohi K; Yasuda Y; Hashimoto R; Inada T; Ujike H; Iidaka T; Suzuki M; Takeda M; Iwata N; Ozaki N
    PLoS One; 2012; 7(5):e36836. PubMed ID: 22649501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
    Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.
    Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
    Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive family-based replication study of schizophrenia genes.
    Aberg KA; Liu Y; Bukszár J; McClay JL; Khachane AN; Andreassen OA; Blackwood D; Corvin A; Djurovic S; Gurling H; Ophoff R; Pato CN; Pato MT; Riley B; Webb T; Kendler K; O'Donovan M; Craddock N; Kirov G; Owen M; Rujescu D; St Clair D; Werge T; Hultman CM; Delisi LE; Sullivan P; van den Oord EJ
    JAMA Psychiatry; 2013 Jun; 70(6):573-81. PubMed ID: 23894747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.
    Green MJ; Cairns MJ; Wu J; Dragovic M; Jablensky A; Tooney PA; Scott RJ; Carr VJ;
    Mol Psychiatry; 2013 Jul; 18(7):774-80. PubMed ID: 22733126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.